Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for its animal health business Merial – the latest in a trend for multi-billion swaps in big pharma. The deal ...
You have full access to this article via your institution. In March, United Kingdom–based animal health firm Merial received conditional approval from the US Department of Agriculture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback